Wishard morphs into Eskenazi Hospital
After suffering for years with decrepit heating and ventilating systems, Wishard, the busiest hospital in the state, finally got a new home. And a new name.
Health Care & Life Sciences
Articles
Analyst: WellPoint will lose money on Obamacare in 2014
Small business dumping, the uncertainty of Obamacare's exchanges, and the certainty of Obamacare's taxes will take a bite out of WellPoint's earnings next year. But company executives remain bullish on Obamacare's long-term impact.
For the holidays: A hopeful, health care reading list
In the Christmas spirit of hope, I’m offering a reading list of several optimistic reports about health care reform—even though many of my recent posts, and the mood of the country in general, have been decidedly downbeat.
Therapist helps seniors, families decide when to relinquish keys
Laura Noblitt is a Zionsville-based occupational therapist with 25 years of experience in geriatric rehabilitation. She has spent half a decade riding shotgun with elderly drivers in central Indiana, determining whether it’s safe for them to stay behind the wheel.
Medicare names names on hospital quality, but don’t expect consumers to notice
The Obama administration has been releasing more price and quality information, but it is coming in a rather useless form for patients. That’s a problem for the prospects of consumer-driven health care.
Lilly, other drugmakers to keep paying doctors
Eli Lilly and Co., Pfizer Inc., Sanofi and other large drugmakers will keep paying doctors to give talks about their products, leaving GlaxoSmithKline Plc alone for now in its decision to halt such compensation.
Insurers give Obamacare enrollees more time for payments
Consumers who enroll in health plans through the new U.S. exchanges will get 10 extra days to pay their first premiums and still gain coverage effective Jan. 1, an insurance company trade group said Wednesday.
Pfizer, Teva reach deal to allow generic Viagra
Fifteen years after Pfizer Inc.’s Viagra changed the sexual equation for older men, the blockbuster impotence drug is set to become available in a less expensive generic form as early as 2017.
Ascension hospitals pledge 549 more service center jobs
Even though St. Louis-based Ascension Health cut nearly 900 jobs this year from its Indianapolis-based hospital subsidiary, St. Vincent Health, it wants to add 549 more to its service center here by 2016.
Two new studies debunk benefits of multivitamins
There's more disappointing news about multivitamins: Two major studies found popping the pills didn't protect aging men's brains or help heart attack survivors.
Hospitals slow to embrace future, survey finds
Hospital executives, in spite of mounting financial pressures under their older business models, are stepping cautiously into the future, with nearly half opting against new accountable care business models touted by Obamacare.
Sorry, docs, but Obamacare will suffer from a shortage
There is good evidence that new technology deployed via new methods of medicine across the entire health care system can reduce the need for physicians. But there are too many barriers for such changes to occur in time to cut off the surge in demand brought on by Obamacare.
Cummins plans wellness center for employees
The facility in Columbus would be the first of its kind for the company. Should the concept prove successful, Cummins will consider similar arrangements in other areas with Cummins plants, said Dr. Dexter Shurney, chief medical officer for Cummins.
Renowned architects creating unique park at Eskenazi Hospital
Eskenazi Health leadership’s desire to connect the diversity of its hospital’s population through a healing park drew in a landscape architect firm that is not only one of the top in the country, but also one of the hottest architecture firms in the world.
Obama team willing to ‘Republicanize’ Medicaid, but maybe not enough for Indiana
A new Medicaid expansion deal with the Republican governor of Iowa OK’d a cost-sharing requirement similar to what Indiana Gov. Mike Pence wants. But the Obama administration says it won’t extend that deal as low as Pence would like to go.
Lilly foe still testing Alzheimer’s theory where others failed
Since 1998, there have been more than 100 attempts to develop an Alzheimer’s treatment, and all have failed. Such a product may generate as much as $5 billion annually for Merck, according to analysts
FDA approves first generic versions of Lilly’s Cymbalta
Cymbalta is Eli Lilly and Co. Inc.'s best-selling drug and posted 2012 sales of $4.7 billion, making it the fifth-highest selling medication in the world. The drug's patent expired Wednesday.
Obamacare exchange enrollment reaches 3,500 in Indiana
Enrollment in November was about four times faster than in October, but it will need to be about 12 times faster through the end of March to meet federal projections.
Indiana extends Healthy Indiana Plan through April
The Family and Social Services Administration announced Tuesday it is extending its Healthy Indiana Plan to participants who earn between 100 percent and 200 percent of the federal poverty level.